170 related articles for article (PubMed ID: 24242739)
1. The prognostic value of cyclin D1 in renal cell carcinoma.
Lima MS; Pereira RA; Costa RS; Tucci S; Dantas M; Muglia VF; Ravinal RC; Barros-Silva GE
Int Urol Nephrol; 2014 May; 46(5):905-13. PubMed ID: 24242739
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of extensive necrosis in renal cell carcinoma.
Collins J; Epstein JI
Hum Pathol; 2017 Aug; 66():108-114. PubMed ID: 28669641
[TBL] [Abstract][Full Text] [Related]
3. Biphasic Squamoid Alveolar Renal Cell Carcinoma: A Distinctive Subtype of Papillary Renal Cell Carcinoma?
Hes O; Condom Mundo E; Peckova K; Lopez JI; Martinek P; Vanecek T; Falconieri G; Agaimy A; Davidson W; Petersson F; Bulimbasic S; Damjanov I; Jimeno M; Ulamec M; Podhola M; Sperga M; Pane Foix M; Shelekhova K; Kalusova K; Hora M; Rotterova P; Daum O; Pivovarcikova K; Michal M
Am J Surg Pathol; 2016 May; 40(5):664-75. PubMed ID: 26999503
[TBL] [Abstract][Full Text] [Related]
4. mTOR and mTOR phosphorylation status in primary and metastatic renal cell carcinoma tissue: differential expression and clinical relevance.
Rausch S; Schollenberger D; Hennenlotter J; Stühler V; Kruck S; Stenzl A; Bedke J
J Cancer Res Clin Oncol; 2019 Jan; 145(1):153-163. PubMed ID: 30368665
[TBL] [Abstract][Full Text] [Related]
5. Cyclin-D1 expression in human renal-cell carcinoma.
Hedberg Y; Davoodi E; Roos G; Ljungberg B; Landberg G
Int J Cancer; 1999 Jun; 84(3):268-72. PubMed ID: 10371345
[TBL] [Abstract][Full Text] [Related]
6. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Significance of Cyclin D1 Expression in Renal Cell Carcinoma: a Systematic Review and Meta-analysis.
Li Z; Liu J; Zhang X; Fang L; Zhang C; Zhang Z; Yan L; Tang Y; Fan Y
Pathol Oncol Res; 2020 Jul; 26(3):1401-1409. PubMed ID: 31748879
[TBL] [Abstract][Full Text] [Related]
8. Combined use of COX-1 and VEGF immunohistochemistry refines the histopathologic prognosis of renal cell carcinoma.
Osman WM; Youssef NS
Int J Clin Exp Pathol; 2015; 8(7):8165-77. PubMed ID: 26339385
[TBL] [Abstract][Full Text] [Related]
9. The L1 cell adhesion molecule is induced in renal cancer cells and correlates with metastasis in clear cell carcinomas.
Allory Y; Matsuoka Y; Bazille C; Christensen EI; Ronco P; Debiec H
Clin Cancer Res; 2005 Feb; 11(3):1190-7. PubMed ID: 15709188
[TBL] [Abstract][Full Text] [Related]
10. Altered expression of key cell cycle regulators in renal cell carcinoma associated with Xp11.2 translocation.
Barroca H; Castedo S; Vieira J; Teixeira M; Müller-Höcker J
Pathol Res Pract; 2009; 205(7):466-72. PubMed ID: 19246164
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Factors for Renal Cell Carcinoma Subtypes Diagnosed According to the 2016 WHO Renal Tumor Classification: a Study Involving 928 Patients.
Kuthi L; Jenei A; Hajdu A; Németh I; Varga Z; Bajory Z; Pajor L; Iványi B
Pathol Oncol Res; 2017 Jul; 23(3):689-698. PubMed ID: 28032311
[TBL] [Abstract][Full Text] [Related]
12. Do Clear Cell Papillary Renal Cell Carcinomas Have Malignant Potential?
Diolombi ML; Cheng L; Argani P; Epstein JI
Am J Surg Pathol; 2015 Dec; 39(12):1621-34. PubMed ID: 26426379
[TBL] [Abstract][Full Text] [Related]
13. Cyclin D1 and p57 expression in relation to clinicopathological characteristics and overall survival in patients with renal cell carcinoma.
Latic D; Pejic S; Savic S; Loncar Z; M Nikolic I; Nikolic G; Pavlovic I; Radojevic-Skodric S
J BUON; 2019; 24(1):301-309. PubMed ID: 30941985
[TBL] [Abstract][Full Text] [Related]
14. p53 expression in correlation to clinical outcome in patients with renal cell carcinoma.
Ljungberg B; Bozoky B; Kovacs G; Stattin P; Farrelly E; Nylander K; Landberg G
Scand J Urol Nephrol; 2001 Feb; 35(1):15-20. PubMed ID: 11291681
[TBL] [Abstract][Full Text] [Related]
15. Clinical significances and prognostic value of cancer stem-like cells markers and vasculogenic mimicry in renal cell carcinoma.
Zhang Y; Sun B; Zhao X; Liu Z; Wang X; Yao X; Dong X; Chi J
J Surg Oncol; 2013 Nov; 108(6):414-9. PubMed ID: 23996537
[TBL] [Abstract][Full Text] [Related]
16. Cyclin D1 and p27 expression as prognostic factor in papillary carcinoma of thyroid: association with clinicopathological parameters.
Pesutić-Pisac V; Punda A; Gluncić I; Bedeković V; Pranić-Kragić A; Kunac N
Croat Med J; 2008 Oct; 49(5):643-9. PubMed ID: 18925698
[TBL] [Abstract][Full Text] [Related]
17. A novel tumor grading scheme for chromophobe renal cell carcinoma: prognostic utility and comparison with Fuhrman nuclear grade.
Paner GP; Amin MB; Alvarado-Cabrero I; Young AN; Stricker HJ; Moch H; Lyles RH
Am J Surg Pathol; 2010 Sep; 34(9):1233-40. PubMed ID: 20679882
[TBL] [Abstract][Full Text] [Related]
18. Cyclin D1 as a therapeutic target of renal cell carcinoma- a combined transcriptomics, tissue microarray and molecular docking study from the Kingdom of Saudi Arabia.
Karim S; Al-Maghrabi JA; Farsi HM; Al-Sayyad AJ; Schulten HJ; Buhmeida A; Mirza Z; Al-Boogmi AA; Ashgan FT; Shabaad MM; NourEldin HF; Al-Ghamdi KB; Abuzenadah A; Chaudhary AG; Al-Qahtani MH
BMC Cancer; 2016 Sep; 16(Suppl 2):741. PubMed ID: 27766950
[TBL] [Abstract][Full Text] [Related]
19. Prognostic implications of the immunohistochemical expression of human kallikreins 5, 6, 10 and 11 in renal cell carcinoma.
Petraki CD; Gregorakis AK; Vaslamatzis MM; Papanastasiou PA; Yousef GM; Levesque MA; Diamandis EP
Tumour Biol; 2006; 27(1):1-7. PubMed ID: 16340244
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive Clinicopathologic Analyses of Acquired Cystic Disease-associated Renal Cell Carcinoma With Focus on Adverse Prognostic Factors and Metastatic Lesions.
Kojima F; Gandhi JS; Matsuzaki I; Iba A; Collier S; Yoshikawa T; Kinoshita Y; Warigaya K; Fujimoto M; Kuroda N; Morii E; Hara I; Murata SI; Amin MB
Am J Surg Pathol; 2020 Aug; 44(8):1031-1039. PubMed ID: 32271189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
